Financial reports
40-F
2012 FY
Annual report (Canada)
21 Sep 12
40-F
2011 FY
Annual report (Canada)
23 Sep 11
40-F
2010 FY
Annual report (Canada)
24 Sep 10
20-F/A
2009 FY
Annual report (foreign) (amended)
4 Mar 10
20-F
2009 FY
Annual report (foreign)
25 Sep 09
20-F
2008 FY
Annual report (foreign)
22 Sep 08
40-F
2007 FY
Annual report (Canada)
24 Sep 07
40-F
2006 FY
Annual report (Canada)
25 Sep 06
40-F/A
2005 FY
Annual report (Canada) (amended)
3 Feb 06
40-F
2005 FY
Annual report (Canada)
29 Sep 05
Current reports
6-K
Current report (foreign)
21 Feb 13
6-K
Gilead Sciences Completes Acquisition of Ym Biosciences
8 Feb 13
6-K
Current report (foreign)
7 Feb 13
6-K
YM BioSciences Reports Operational and Financial Results for the Second Quarter of Fiscal 2013
7 Feb 13
6-K
Current report (foreign)
5 Feb 13
6-K
YM BioSciences Shareholders Approve Plan of Arrangement with Gilead Sciences
31 Jan 13
6-K
Current report (foreign)
18 Jan 13
6-K
Notice of Special Meeting of Shareholders
10 Jan 13
6-K
YM BioSciences Announces Record Date for Previously Announced Plan of Arrangement
21 Dec 12
6-K
Gilead Sciences to Acquire Ym Biosciences
12 Dec 12
Registration and prospectus
15-12B
Securities registration termination
22 Feb 13
F-10POS
Automatic registration of securities (post-effective amendment, Canada)
15 Feb 13
S-8 POS
Registration of securities for employees (post-effective amendment)
15 Feb 13
25-NSE/A
Exchange delisting (amended)
12 Feb 13
25-NSE
Exchange delisting
12 Feb 13
SUPPL
Supplemental materials (foreign)
25 May 12
SUPPL
Supplemental materials (foreign)
24 Feb 12
FWP
Free writing prospectus
24 Feb 12
SUPPL
Supplemental materials (foreign)
23 Feb 12
F-10/A
Registration of securities (Canada) (amended)
14 Jul 11
Proxies
No filings
Other
EFFECT
Notice of effectiveness
15 Jul 11
EFFECT
Notice of effectiveness
1 Dec 10
UPLOAD
Letter from SEC
25 May 10
CORRESP
Correspondence with SEC
14 May 10
UPLOAD
Letter from SEC
7 May 10
CT ORDER
Confidential treatment order
21 Apr 10
CORRESP
Correspondence with SEC
12 Apr 10
UPLOAD
Letter from SEC
31 Mar 10
CORRESP
Correspondence with SEC
4 Mar 10
CORRESP
Correspondence with SEC
2 Mar 10